Right To Try” law was designed to boost terminally ill patients’ access to potentially lifesaving medications not yet ...

The FDA’s REMS policy, designed to ensure drug safety, is instead harming individuals with treatment-resistant schizophrenia ...

The FDA announced a new pilot program for communication of medical device recalls, but industry may be wary of a program that ...

The U.S. Food and Drug Administration (FDA) has released guidance with revisions to the Food Safety Modernization Act Voluntary Qualified ...

On November 21, 2024, the FDA’s Center for Devices and Radiological Health (CDRH) announced a pilot communications program ...

Polymyositis is an autoimmune disease that causes inflammation and weakness of the skeletal muscles responsible for movement.